Skip to main content
OpenTrials
Completed

NCT Number: NCT05736237

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen Development

The goal of this observational study is to learn about the genetic background for the development of optic disc drusen. The main question is:

• Can one or more candidate genes be found?

Participants will have a blood sample taken and answer a questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology

Glostrup Municipality, 2600, Denmark

About this study

The study is an international collaboration between University of Utah, University of Sydney, University of Valladolid, and University of Copenhagen. Patients with Optic disc drusen from 15 known optic disc drusen-families from different countries (USA, Australia, Spain and Denmark) are participating in this study.

Blood samples are drawn from each patient and their affected and unaffected family members, and DNA will be extracted. The investigators will do an Optical coherence tomography-scan (according to ODDS Consortium guidelines), and the participant will be asked to fill out the Visual Function Questionnaire (VFQ-25) including four additional questions about optic disc drusen.

The etiology of optic disc drusen will be analyzed with a Whole Exome Sequencing (WES), with the use of Next Generation Sequencing (NGS). Prior to WES, all participants will receive genetic counseling by a consultant to ensure awareness of possible secondary genetic findings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients over the age of 18, who are capable of giving consent
  • Diagnosis of optic disc drusen and a minimum of 3 optic disc drusen-affected family members

Exclusion criteria

  • Less than 3 affected family members
  • Under the age of 18 or mentally disabled

Treatment and study plan

Whole Exome Sequencing

Genetic

With Next Generation Sequenzing

Primary outcomes

  1. Candidate gene

    Time frame: 2023-2024

    Genetics variants shared by the families will be compared with findings in the remaining families and identical genes will undergo further analysis.

Sponsors and collaborators

Lead sponsor

Copenhagen University Hospital at Herlev

Other

Registry information

Official study title

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen

Acronym: GENODD

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Feb 21, 2023
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.